Reasons to Retain Quest Diagnostics (DGX) Stock for Now
Yahoo FinanceMay 2 10:42 ET
Quest Diagnostics (DGX) Inks Deal to Acquire PathAI Diagnostics
Yahoo FinanceMay 2 09:02 ET
Quest Supports Expansion of Community Center and Provides No-Cost Wellness Testing to Newark Faith Community
NORTHAMPTON, MA / ACCESSWIRE / May 2, 2024 / Quest Diagnostics:At a glance:Quest worked with St. James Health in Newark to provide no-cost Blueprint for Wellness screenings during a Choose Healthy Lif
AccesswireMay 2 08:10 ET
Quest Diagnostics(DGX.US) Officer Sells US$246.4K in Common Stock
$Quest Diagnostics(DGX.US)$ Officer KUPPUSAMY KARTHIK sold 1,760 shares of common stock on Apr 29, 2024 at an average price of $140 for a total value of $246.4K.Source: Announcement What is statement
moomoo NewsMay 1 17:09 ET
Quest Diagnostics To Acquire Select Assets Of PathAI Diagnostics - Quick Facts
RTTNewsMay 1 07:25 ET
Express News | Quest Diagnostics Announced A Multi-faceted Collaboration Designed To Accelerate The Adoption Of Digital And AI Pathology Innovations To Improve Quality, Speed And Efficiency In Diagnosing Cancer And Other Diseases
BenzingaMay 1 06:58 ET
Quest Diagnostics Forms Licensing Agreements With PathAI >DGX
Quest Diagnostics Forms Licensing Agreements With PathAI >DGX
Dow JonesMay 1 06:58 ET
Express News | Quest Diagnostics to Acquire Pathai Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements With Pathai
ReutersMay 1 06:57 ET
Baird Adjusts Quest Diagnostics' Price Target to $144 From $138
Quest Diagnostics (DGX) has an average rating of outperform and price targets ranging from $136 to $160, according to analysts polled by Capital IQ. Price: 139.60, Change: +0.10, Percent Change: +0.07
MT NewswiresApr 30 08:37 ET
Piper Sandler Reaffirms Their Hold Rating on Quest Diagnostics (DGX)
TipRanksApr 30 07:06 ET
Express News | NYSE Order Imbalance 136389.0 Shares on Buy Side
ReutersApr 29 15:50 ET
Express News | Quest Diagnostics Shares Are Trading Higher. The FDA Reportedly Finalized Its Rules That Aim to Bring Lab-developed Tests in Line With How It Oversees Other Diagnostics
BenzingaApr 29 15:12 ET
Form 144 | Quest Diagnostics(DGX.US) Officer Proposes to Sell 246.4K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 29, $Quest Diagnostics(DGX.US)$ Officer KUPPUSAMY KARTHIK intends to sell 1,760 shares of its common stock on Apr 29, with a total market value of approximately $246.4K.
moomoo NewsApr 29 12:40 ET
Quest Diagnostics, LabCorp Climb Following FDA Testing Oversight Rule
Seeking AlphaApr 29 11:45 ET
Quest Diagnostics Up Over 5%, on Pace for Largest Percent Increase Since October 2022 -- Data Talk
Quest Diagnostics Incorporated (DGX) is currently at $141.24, up $6.99 or 5.2% --Would be highest close since Jan. 9, 2024, when it closed at $142.11 --On pace for largest percent increase since Oct
Dow JonesApr 29 11:12 ET
Analysts Have Conflicting Sentiments on These Healthcare Companies: Apellis Pharmaceuticals (APLS), Quest Diagnostics (DGX) and Healthcare Services (HCSG)
TipRanksApr 26 03:08 ET
Quest Diagnostics: A Hold Rating Amid Solid Earnings and Strategic Caution
TipRanksApr 26 02:15 ET
Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insight
Yahoo FinanceApr 26 01:05 ET
Quest Diagnostics Is Maintained at Equal-Weight by Barclays
Quest Diagnostics Is Maintained at Equal-Weight by Barclays
Dow JonesApr 25 14:47 ET
Barclays Maintains Equal-Weight on Quest Diagnostics, Raises Price Target to $144
Barclays analyst Stephanie Davis maintains Quest Diagnostics (NYSE:DGX) with a Equal-Weight and raises the price target from $138 to $144.
BenzingaApr 25 14:36 ET
No Data
No Data